Trials / Completed
CompletedNCT02115308
Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Timothy M. Bateman · Academic / Other
- Sex
- All
- Age
- 19 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to measure the changes in cardiac function during a Lexiscan pharmacologic stress test using cardiac magnetic resonance imaging test.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Regadenoson | Regadenoson injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging. |
Timeline
- Start date
- 2014-09-03
- Primary completion
- 2018-01-16
- Completion
- 2018-03-23
- First posted
- 2014-04-16
- Last updated
- 2018-09-19
- Results posted
- 2018-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02115308. Inclusion in this directory is not an endorsement.